Key result
Physicians rarely initiate discussions about ICD deactivation at the end of life due to the device's small internal nature, its primary life-saving role, lack of established patient rapport, and general concerns about withdrawing care.
Why the study?
What are the barriers preventing physicians from discussing the deactivation of implantable cardioverter defibrillators at the end of life?
What are the barriers preventing physicians from discussing the deactivation of implantable cardioverter defibrillators at the end of life?
ICDs possess unique characteristics that make end-of-life deactivation discussions difficult for physicians, highlighting a need for targeted educational interventions.
Answers are grounded in this paper and cite their sources.
Barriers to end-of-life ICD deactivation discussions warrant clinician awareness; leaves open whether targeted education improves communication practices.
OBJECTIVE: To understand potential barriers to physician-initiated discussions about Implantable Cardioverter Defibrillator (ICD) deactivation in patients with advanced illness. DESIGN: Qualitative one-on-one interviews. PARTICIPANTS: Four electrophysiologists, 4 cardiologists, and 4 generalists (internists and geriatricians) from 3 states. APPROACH: Clinicians were interviewed using open-ended questions to elicit their past experiences with discussing deactivating ICDs and to determine what barriers might impede these discussions. Transcripts of these interviews were analyzed using the qualitative method of constant comparison. RESULTS: Although many physicians believed that conversations about deactivating ICDs should be included in advance care planning discussions, they acknowledged that they rarely did this. Physicians indicated that there was something intrinsic to the nature of these devices that makes it inherently difficult to think of them in the same context as other management decisions at the end of a patient's life. Other explanations physicians gave as to why they did not engage in conversations included: the small internal nature of these devices and hence absence of a physical reminder to discuss the ICD, the absence of an established relationship with the patient, and their own general concerns relating to withdrawing care. CONCLUSION: Whereas some of the barriers to discussing ICD deactivation are common to all forms of advance care planning, ICDs have unique characteristics that make these conversations more difficult. Future educational interventions will need to be designed to teach physicians how to improve communication with patients about the management of ICDs at the end of life.
No takes yet. Share an insight, caveat, or question.
Goldstein et al. (2007) studied Physicians managing patients with Implantable Cardioverter Defibrillators (ICDs) at the end of life (n=12). Discussions about ICD deactivation was evaluated on Barriers to physician-initiated discussions about ICD deactivation. Physicians rarely initiate discussions about ICD deactivation at the end of life due to the device's small internal nature, its primary life-saving role, lack of established patient rapport, and general concerns about withdrawing care.
Synapse has enriched 10 related papers. Consider them for comparative context: